NCT03755193View on ClinicalTrials.gov

Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 24, 2018

Primary Completion Date

November 23, 2024

Study Completion Date

November 23, 2026

Conditions
Osteoporosis
Interventions
DRUG

"SERM Viviant®Tablet 20mg and ELD Edirol®Tablet 0.75ug"

To examine the effects of SERM and ELD in osteoporosis patients

DRUG

"Bisphosphonates and ELD Edirol®Tablet 0.75ug"

To examine the effects of BP and ELD in osteoporosis patients

DRUG

"ELD Edirol®Tablet 0.75ug"

To examine the effects of ELD in osteoporosis patients

Trial Locations (1)

3908621

RECRUITING

Yukio Nakamura, Matsumoto

All Listed Sponsors
lead

Shinshu University

OTHER